...
首页> 外文期刊>BMC Cancer >Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing
【24h】

Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing

机译:1990 - 2018年法国癌症发病率和死亡率趋势对于实体肿瘤:性差距缩小

获取原文
           

摘要

To analyze trends in cancer incidence and mortality (France, 1990–2018), with a focus on men-women disparities. Incidence data stemmed from cancer registries (FRANCIM) and mortality data from national statistics (CépiDc). Incidence and mortality rates were modelled using bidimensional penalized splines of age and year (at diagnosis and at death, respectively). Trends in age-standardized rates were summarized by the average annual percent changes (AAPC) for all-cancers combined, 19 solid tumors, and 8 subsites. Sex gaps were indicated using male-to-female rate ratios (relative difference) and male-to-female rate differences (absolute difference) in 1990 and 2018, for incidence and mortality, respectively. For all-cancers, the sex gap narrowed over 1990–2018 in incidence (1.6 to 1.2) and mortality (2.3 to 1.7). The largest decreases of the male-to-female incidence rate ratio were for cancers of the lung (9.5 to 2.2), lip - oral cavity - pharynx (10.9 to 3.1), esophagus (12.6 to 4.5) and larynx (17.1 to 7.1). Mixed trends emerged in lung and oesophageal cancers, probably explained by differing risk factors for the two main histological subtypes. Sex incidence gaps narrowed due to increasing trends in men and women for skin melanoma (0.7 to 1, due to initially higher rates in women), cancers of the liver (7.4 to 4.4) and pancreas (2.0 to 1.4). Sex incidence gaps narrowed for colon-rectum (1.7 to 1.4), urinary bladder (6.9 to 6.1) and stomach (2.7 to 2.4) driven by decreasing trends among men. Other cancers showed similar increasing incidence trends in both sexes leading to stable sex gaps: thyroid gland (0.3 to 0.3), kidney (2.2 to 2.4) and central nervous system (1.4 to 1.5). In France in 2018, while men still had higher risks of developing or dying from most cancers, the sex gap was narrowing. Efforts should focus on avoiding risk factors (e.g., smoking) and developing etiological studies to understand currently unexplained increasing trends.
机译:分析癌症发病率和死亡率的趋势(法国,1990-2018),重点关注男性女性差异。来自国家统计(Cép​​idc)的癌症注册表(Francim)和死亡率数据源于癌症注册表(Cépidc)的发病率数据。使用年度惩罚年龄和年龄(分别在诊断和死亡)的竞争惩罚均衡发生率和死亡率。年龄标准化率的趋势总结了所有癌症,19种实体肿瘤和8个底座的平均年度百分比变化(AAPC)。用男性对女性率比(相对差异)和20世纪1990年和2018年的男女率差异(绝对差异)表示性差距,分别为发病率和死亡率。对于所有癌症,性差距在1990 - 2018年发生的发生(1.6至1.2)和死亡率(2.3至1.7)。雄性发生率的最大降低是肺部(9.5至2.2)的癌症(9.5至2.2),唇部腔 - 咽部(10.9至3.1),食道(12.6至4.5)和喉部(17.1至7.1) 。肺癌和食管癌中出现的混合趋势可能是通过两种主要组织学亚型的不同风险因素解释。由于男性和女性的趋势增加了皮肤黑素瘤的趋势(妇女最初较高的速率),肝脏(7.4至4.4)和胰腺(2.0至1.4)的癌症(2.0至1.4)的趋势,性病发生率缩小(0.7〜1。性发生率差距变窄(1.7至1.4),膀胱(6.9至6.1)和胃(2.7至2.4)通过降低男性趋势而导致的胃(2.7至2.4)。其他癌症表现出类似的两性发病率趋势,导致稳定的性别差距:甲状腺(0.3〜0.3),肾(2.2至2.4)和中枢神经系统(1.4至1.5)。在2018年的法国,而男性仍然从大多数癌症开发或死亡的风险较高,而性差距则缩小。努力应专注于避免风险因素(例如,吸烟)和发展病因研究以了解目前无法解释的增加趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号